NMPA Issues Guidelines on Medical Device Grading Administration
The National Medical Products Administration (NMPA) has released a set of Guiding Opinions on “Medical...
Frontier Biotech’s FB2001 Inhalant Accepted for NMPA Review
China-based Frontier Biotechnologies Inc. (SHA: 688221) announced that a registrational clinical filing for its FB2001...
Luye Pharma’s LY03015 Receives FDA Approval for Phase I Clinical Study
China-based Luye Pharma Group (HKG: 2186) announced that it has received approval from the US...
Hengrui Medicine to Incentivize Employees with Share Distribution
China-based Jiangsu Hengrui Medicine Co., Ltd (SHA: 600276) has announced plans to incentivize its employees...
Biden’s Executive Order Boosts US Bio-Economy, Targets China’s Biotech Rise
US President Joe Biden signed an executive order on Monday, outlining steps to bolster the...
QuantuMDx and Sansure Biotech Partner to Commercialize Q-POC in China
UK-based QuantuMDx Group Ltd announced a global R&D, manufacturing, and commercial partnership with China’s Sansure...
InnoCare Pharma’s BCL2 Inhibitor ICP-248 Gains NMPA Approval for Clinical Study
China’s Beijing InnoCare Pharma (HKG: 9969) announced that it has received approval from the National...
BeiGene’s Tislelizumab Meets Primary Endpoint in HCC Study at ESMO
BeiGene (NASDAQ: BGNE, HKG: 6160, SHA: 688235) presented the latest results of the global Phase...
Luye Pharma’s BA-CovMab Receives NMPA Approval for COVID-19 Clinical Trials
China-based Luye Pharma Group (HKG: 2186) announced that its subsidiary Shandong BoAn Biotechnology Co., Ltd’s...
Jiangsu Healthcare to Cover All Psychological Treatments Under BMI
The Jiangsu Provincial Healthcare Security Administration is reportedly considering adding all psychological diagnosis and treatment...
Leadinno Medical Valley Raises RMB 100M in Series A Financing for Neuromodulation Devices
Beijing-based neuromodulation medical device maker Leadinno Medical Valley reportedly raised over RMB 100 million (USD...
Transcenta’s TST001 Shows Promise in Gastric Cancer Trial with 73.3% Response Rate
China-based biotech Transcenta Holdings Ltd (HKG: 6628) announced interim safety and efficacy data from a...
CSPC Pharmaceutical’s TG103 Gains NMPA Approval for NASH and Alzheimer’s Trials
China-based CSPC Pharmaceutical Group Co., Ltd (HKG: 1093) announced that it has received approval from...
Jingxin Pharmaceutical Receives NMPA Approval for JBPOS0101 and JX7002 Trials
Jingxin Pharmaceutical Co., Ltd (SHE: 002020) announced that it has received clinical trial approvals from...
China’s Retail Pharmacy O2O Sales Surge to USD 2.9B in 2021
According to the “China Retail Pharmacy O2O Development Report” released by Minenet, the “online drug...
National High-Value Medical Consumables VBP Round Targets Orthopedic Spine Products
The national high-value medical consumables joint procurement office released a set of guiding opinions on...
China’s Cecolin HPV Vaccine Shows 100% Efficacy in 66-Month Study
Chinese researchers have published 66-month follow-up data from a Phase III clinical study for the...
Dizal Pharma’s Sunvozertinib Gains NMPA Approval for EGFR Mutation NSCLC Trial
China-based Dizal Pharmaceutical Co., Ltd (SHA: 688192) announced that it has received clinical trial approval...
MofCOM’s 2021 Pharma Distribution Report Shows Market Recovery
The Ministry of Commerce (MofCOM) released its annual statistical review of the pharma distribution industry...
NHSA Issues Notice on Special Treatment of Oral Implant Medical Service Charges
The National Healthcare Security Administration (NHSA) has released a Notice on “Carrying out Special Treatment...